Harnessing artificial intelligence to transform Alzheimer's disease research
- PMID: 40169865
- DOI: 10.1038/s41591-025-03632-8
Harnessing artificial intelligence to transform Alzheimer's disease research
Conflict of interest statement
Competing interests: P.M.D. is supported by NIH 2RO1 AG052440 and U19AG024904, Cure Alzheimer’s Fund, Karen L Wrenn Trust, Gates Ventures, lululemon and Steve Aoki Foundation; has received advisory fees from and/or owns shares in several healthcare, biopharmaceutical and technology companies; is a co-inventor (through his university) on several patents; and serves on the board of directors of AHEL. G.J.M. receives advisory fees from Gates Ventures; and owns shares and/or serves as a director on the boards of several healthcare, biopharmaceutical, and technology companies. J.R.P. is funded by grants from NSF (DMS-2052676), NIH (P30AG072958, U01AG024904, NS134726) and Gates Ventures, and has served on the medical advisory boards for Cortechs.ai, Biogen and icometrix. The other authors declare no competing interests.
References
Publication types
LinkOut - more resources
Full Text Sources